Our Studies

To date, we have successfully completed over 500 FDA-approved studies in the areas of allergy, asthma and immunological diseases. At any given time, we are running numerous studies, advancing the frontiers of research and the possibilities of treatments every day.

CURRENT STUDIES

To apply to participate in one of our studies, please go here. If you would like to participate in a specific study, please note that when you fill out our survey.

Alladapt – Multi Food OIT Study

Study Treatment: 15 food oral immunotherapy
Subjects: 4-55 years of age with food allergy

For full information go to this link in clinicaltrials.gov

Regeneron – Adolescent and Adult Cat Allergy Study

Study Treatment: REGN1908-1909
Subjects: 12 years of age and older with cat allergen-triggered allergic rhinitis

For full information go to this link in clinicaltrials.gov

COUR – Adult Peanut Allergy Study

Study Treatment: CNP-201
Subjects: 16-55 with peanut allergy

For full information go to this link in clinicaltrials.gov

Takeda – Hereditary Angioedema Study

Real-world effectiveness of Lanadelumab
Subjects: HAE Type 1 or 2

For full information go to this link in clinicaltrials.gov

Interested in Participating in a Study?

GET INVOLVED

If you are eligible you will be contacted by one our research coordinators.

Siolta – Prevention of Type I Allergic Diseases Study

Study Treatment: STMC-103H
Subjects: Children 1 year to <6 years of age

For full information go to this link in clinicaltrials.gov

ONGOING STUDIES
(NO FURTHER ENROLLMENT)

  • Aimmune AIME01

  • Aimmune Rollover ARC008

  • Biocryst – HAE Study
  • DBV EPITOPE/ EPOPEX

  • DBV MILES

  • DBV PEPITES/PEOPLE

  • DBV REALISE

  • Regeneron R668-ALG-16114
  • Regeneron R668-EE-1774
  • Astellas MATRIX II
  • UW Hallstrand Asthma Study
  • Regeneron E668-AS-1885
  • Takeda SHP643-403

  • AstraZeneca MANDARA